Title:
DNAおよび抗原の併用により作用増強したワクチン製剤
Document Type and Number:
Japanese Patent JP2004537552
Kind Code:
A
Abstract:
The invention relates to a vaccine antigen formulation containing the following main components: a-) one or more DNAs that express one or more proteins in the immunized individual and b-) a viral antigen, in suitable proportions. The novelty of the invention lies in the potentiating effect exerted by at least one of the components on the immune response generated against the other. The invention also relates to the development of novel formulations, that minimize the number of components that can amplified and potentiate the range of immune response against different pathogenic entities. Said formulation are suitable for use in the pharmaceutical industry for prophylactic and/or therapeutic purposes in individuals.
Inventors:
Duenas Carrera, Santiago
Morales Grillo, fan
Alvarez-La Fonquere Ponce de Leon, Liz
Musaccio Lhasa, Alexis
Pafon Fate, Roland
Vigna Rodriguez, Ariel
Alvarez Obregon, Julio, Sea
Acosta Rivero, Nelson
Martinez Donato, Gillian
Morales Grillo, fan
Alvarez-La Fonquere Ponce de Leon, Liz
Musaccio Lhasa, Alexis
Pafon Fate, Roland
Vigna Rodriguez, Ariel
Alvarez Obregon, Julio, Sea
Acosta Rivero, Nelson
Martinez Donato, Gillian
Application Number:
JP2003513591A
Publication Date:
December 16, 2004
Filing Date:
July 12, 2002
Export Citation:
Assignee:
Centro in the Any Area Energy Biotechnology
International Classes:
A61K39/29; A61P31/14; A61P31/20; A61K39/39; A61K; (IPC1-7): A61K39/39; A61K39/29; A61P31/14; A61P31/20
Attorney, Agent or Firm:
Hideto Asamura
Hajime Asamura
Naganuma Akio
Yukihiro Ikeda
Hajime Asamura
Naganuma Akio
Yukihiro Ikeda
Previous Patent: メトトレキサートに基づく薬剤を投与することによって腫瘍性、血管原性...
Next Patent: アルドステロン受容体アンタゴニストおよびＨＭＧＣｏ−Ａレダクターゼ...
Next Patent: アルドステロン受容体アンタゴニストおよびＨＭＧＣｏ−Ａレダクターゼ...